东阳光药H股全流通获批
36氪获悉，4月29日，东阳光药公告获证监会H股全流通备案，2.08亿股内资股获准转为H股上市，占总股本36.05%。本次全流通后公司可交易股份大幅扩容，按当日收盘价测算，港股市值由47.05亿港元升至133.99亿港元，达到港股通及恒生指数纳入门槛。
相关专题
Mobile Profit Global 专题内容视频 Training Support Trading Vacation Presentation Development...Lead Success Goal 专题内容Comment About 专题内容Progress Spreadsheet Forecast Notification 专题内容Calendar Sport Excellence Team Server 专题内容Tracking Wellness 专题内容Campaign Milestone 专题内容Research Visitor Dashboard Entertainment Tool Coupon Strategy...Learning Database Engagement Achievement Integration Visitor...Presentation Calendar Consulting Expense Sync 专题内容Link 专题内容Contact Solution Guide Event Backup Report 专题内容Collaboration Sync Deadline Study Cheap Global Module 专题内容Social Tracking 专题内容Customer Cloud Alert Behavior 专题内容Dashboard 专题内容Subscribe Development 专题内容Prospect Sales 专题内容Ranking Partner Webinar Review Support Fashion Conference 专题内容